CAS No: 18086-25-4

1808-63-5 3beta-hydroxy-16-methylpregna-5,16-dien-20-one

180895-43-6 HYDRAZINECARBOXYLIC ACID 2-(TRIFLUOROACETYL)-,METHYL ESTER

16608-68-7 2-Butene, 3-chloro-1-phenyl-, (Z)-

180894-78-4 Octadecanoic acid,(1S)-1-[[(4-methoxyphenyl)methoxy]methyl]-2-[[1-oxo-6-[[(phenylmethoxy)carbonyl]amino]hexyl]oxy]ethyl ester

16607-58-2 3-(dimethylamino)-4,6-diphenylpyridin-2(1H)-one

18086-33-4 (2-ETHOXY-5-METHOXYPHENYL)-ACETIC ACID

180889-29-6 Methanimidamide, N-(1,2-dihydroxyethyl)-N,N-dimethyl-, [R-(E)]- (9CI)

180866-58-4 SP 16A

180894-18-2 L-Serine, N-[N-[bis(1-methylethoxy)phosphinyl]-L-histidyl]-

180889-34-3 METHANIMIDAMIDE,N-(1,2-DIHYDROXYETHYL)-N,N-DIMETHYL-,[R-(E)]-

166090-01-3 Butanedioic acid,monopolyisobutylene derivs., compds. with 1-(dimethylamino)-2-propanol (1:2)

166090-00-2 Carbonic acid, dimethylester, polymer with a-hydro-w-hydroxypoly(oxy-1,2-ethanediyl),ether with polyethylene glycol monodecyl ether

180863-04-1 3-PYRIDINECARBOXYLIC ACID,2-ETHOXY-3,4,5,6-TETRAHYDRO-4-METHYL-,ETHYL ESTER

180868-14-8 2,4-Pentadienoic acid, 5-(5,6-dichloro-1H-indol-2-yl)-2-methoxy-,(2Z,4E)-

166090-74-0 H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA-OH

180889-32-1 ETHANIMIDAMIDE,N-(1,2-DIHYDROXYETHYL)-N,N-DIMETHYL-,[R-(E)]-

166089-32-3 Lintuzumab

166089-99-2 Formaldehyde, polymers with bisphenol A, 2-(diethylamino)ethanol, melamine and melamine 2-(2-hydroxyethoxy)ethyl derivs.

18089-32-2 (20R)-11β,17-Dihydroxy-20,21-[isopropylidenebisoxy]pregna-1,4-dien-3-one

18088-13-6 1,1,1,3-TETRACHLOROOCTANE